283 results on '"Inaba, Tomoki"'
Search Results
2. Long-term outcomes of patients with primary intestinal follicular lymphoma managed with watch-and-wait strategy
3. Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
4. Effectiveness of second-look endoscopy after gastric endoscopic submucosal dissection in patients taking antithrombotic agents: a multicenter propensity score matching analysis
5. AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
6. Nonrecurrence Rate of Underwater EMR for ≤20-mm Nonampullary Duodenal Adenomas: A Multicenter Prospective Study (D-UEMR Study)
7. Endoscopic features of oxyntic gland adenoma and gastric adenocarcinoma of the fundic gland type differ between patients with and without Helicobacter pylori infection: a retrospective observational study
8. The Risk of Metastatic Recurrence after Non-Curative Endoscopic Resection with Negative Deep Margins for Early Colorectal Cancer: Two-Center Retrospective Cohort Study.
9. Predictive Factors for Efficacy of Oral Tacrolimus Induction Therapy in Moderate to Severe Ulcerative Colitis Patients: Large Multicenter Retrospective Cohort Study.
10. Conversion surgery of Stage IV gastric cancer with peritoneal dissemination after nivolumab
11. Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
12. Correction to: Effectiveness of second-look endoscopy after gastric endoscopic submucosal dissection in patients taking antithrombotic agents: a multicenter propensity score matching analysis
13. Neuroendocrine carcinoma arising from Barrett’s esophageal adenocarcinoma: a case report
14. Anti-proteinase 3 antineutrophil cytoplasmic antibody reflects disease activity and predicts the response to steroid therapy in ulcerative colitis
15. Endoscopic resection is a suitable initial treatment strategy for oxyntic gland adenoma or gastric adenocarcinoma of the fundic gland type
16. Lesion size, elevated morphology, and non or closed-type atrophy are predictive factors for gastric adenocarcinoma of the fundic gland type rather than oxyntic gland adenoma
17. Clinical characteristics and course of sporadic non-ampullary duodenal adenomas: A multicenter retrospective study
18. Results of the interim analysis of a prospective, multicenter, observational study of small subepithelial lesions in the stomach.
19. Predictive Factors for Efficacy of Oral Tacrolimus Induction Therapy in Moderate to Severe Ulcerative Colitis Patients: Large Multicenter Retrospective Cohort Study
20. Results of the interim analysis of a prospective, multicenter, observational study of small subepithelial lesions in the stomach
21. Safety and efficacy of capsule endoscopy for patients with newly diagnosed Crohn’s disease: A multicenter retrospective study
22. AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
23. Simultaneous Measurements of Faecal Calprotectin and the Faecal Immunochemical Test in Quiescent Ulcerative Colitis Patients Can Stratify Risk of Relapse
24. Bleeding in patients who underwent scheduled second-look endoscopy 5 days after endoscopic submucosal dissection for gastric lesions
25. Nonrecurrence Rate of Underwater EMR for ≤20-mm Nonampullary Duodenal Adenomas: A Multicenter Prospective Study (D-UEMR Study)
26. Additional file 1 of Endoscopic features of oxyntic gland adenoma and gastric adenocarcinoma of the fundic gland type differ between patients with and without Helicobacter pylori infection: a retrospective observational study
27. Endoscopic Features of Oxyntic Gland Adenoma and Gastric Adenocarcinoma of the Fundic Gland Type Differ Between Patients with and Without Helicobacter pylori Infection: A Retrospective Observational Study
28. Dasatinib-induced colitis: clinical, endoscopic and histological findings
29. Risk factors and prediction of bleeding after gastric endoscopic submucosal dissection in patients on antithrombotic therapy: newly developed bleeding prediction application software, SAMURAI model
30. SIGNIFICANCE OF EUS IN THE FOLLOW-UP OF SMALL SUBEPITHELIAL LESIONS IN THE STOMACH: A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY.
31. Efficacy of vonoprazan against bleeding from endoscopic submucosal dissection-induced gastric ulcers under antithrombotic medication: A cross-design synthesis of randomized and observational studies
32. Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis
33. Delayed perforation after endoscopic band ligation for treatment of colonic diverticular bleeding
34. Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan
35. A multicenter survey of enteroscopy for the diagnosis of intestinal follicular lymphoma
36. Long-term follow-up of extremely elderly patients with early gastric neoplasms treated by endoscopic submucosal dissection: P-747
37. Clinical study on performing upper gastrointestinal biopsy with small cup biopsy forceps in patients receiving antiplatelet agents: P-320
38. Efficacy of sedation by propofol during endoscopic submucosal dissection(esd): P-087
39. Efficacy and safety of endoscopic submucosal dissection for gastric tube cancer: A multicenter retrospective study
40. Risk Factors and Prediction of Bleeding after Endoscopic Submucosal Dissection in Patients on Antithrombotic Therapy: The SAMURAI Model
41. Clinical Questions and Answers on Gastrointestinal Endoscopy during the Novel COVID‐19 Pandemic
42. Exposed blood vessels of more than 2 mm in diameter are a risk factor for rebleeding after endoscopic clipping hemostasis for hemorrhagic gastroduodenal ulcer
43. Risk factors for perforation and delayed bleeding associated with endoscopic submucosal dissection for early gastric neoplasms: Analysis of 1123 lesions
44. Serum anti-proteinase 3 anti-neutrophil cytoplasmic antibody in ulcerative colitis: a potential marker of disease activity that predicts steroid therapy failure
45. Clinical Questions and Answers on Gastrointestinal Endoscopy during the Novel Coronavirus Disease 2019 pandemic
46. Gastrointestinal endoscopy in the era of the acute pandemic of coronavirus disease 2019: Recommendations by Japan Gastroenterological Endoscopy Society (Issued on April 9th, 2020)
47. Stool decay-accelerating factor as a marker for monitoring the disease activity during leukocyte apheresis therapy in patients with refractory ulcerative colitis
48. The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5 ′-deoxy-5-fluorouridine
49. Mucin-histochemical and immunohistochemical profiles of epithelial cells of several types of hepatic cysts
50. Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.